Viewing StudyNCT06339619



Ignite Creation Date: 2024-05-06 @ 8:18 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06339619
Status: RECRUITING
Last Update Posted: 2024-04-01
First Post: 2024-03-25

Brief Title: Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma
Sponsor:
Organization: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University